AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Methotrexate in South Africa

10 products registered with SAHPRA 5 active

Brand / ProductReg. No.HolderStatusExpires
P & U METHOTREXATE CSV 50 mg/2 ml INJECTION30/26/0311Pfizer Laboratories (Pty) Ltdsuspended27 Feb 2024
P&U METHOTREXATE CSV 1000 mg/10 ml INJECTION34/26/0226Pfizer Laboratories (Pty) Ltdsuspended27 Feb 2024
METHOTREXATE-FAULDING 25 mg/ml29/26/0363Pfizer Laboratories (Pty) Ltdsuspended27 Feb 2024
P & U METHOTREXATE CSV 500 mg/20 ml INJECTION29/26/0502Pfizer Laboratories (Pty) Ltdsuspended27 Feb 2024
EMTHEXATE 50 mgS/26/346PHARMACHEMIE (PTY) LTDsuspended1 Aug 2015
ABITREXATE 500T/26/64Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
ABITREXATE 50T/26/63Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
ABITREXATE 1 gT/26/57Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
ABITREXATE 5gW/26/386Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900
ABITREXATE 2,5 mg37/26/0466Teva Pharmaceuticals (Pty) Ltdactive1 Jan 1900

MethotrexateSAHPRA Registration Details

SAHPRA (South Africa) has 10 registered products containing Methotrexate, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Methotrexate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.